Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists

Rasmus M Christensen, Christian R Juhl, Signe S Torekov

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds